Clinical Trials Directory

Trials / Unknown

UnknownNCT05111808

Feasibility Trial for Real-time Identification of the Ureters With a Methylene-blue

A Non-Randomized, Prospective, Open Label, Single-site Feasibility Trial for Real-time Identification of the Ureters With a Methylene-blue fluoroPhore

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
University College, London · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a non-randomized prospective, open label, single site study to evaluate the feasibility of recruitment for the use of an Investigational Endoscopic Fluorescence Imaging System, PINPOINT, in intraoperative bilateral visualization of ureters using intravenous injection of methylene blue. Feasibility of urine sample collection during surgery will also be assessed.

Detailed description

Background - During certain abdominal surgeries there is difficulty in finding the ureters, which act as a conduit for urine from the kidneys to the bladder. If the ureters are sectioned during surgery this causes great suffering for the patient and increased costs for the hospital and the National Health Service. Even experienced surgeons are at risk of causing this dreaded complication. Methylene blue can emit a fluorescent signal and highlight the ureters in real time during surgical procedures. A study is necessary to evaluate the effectiveness of methylene blue fluorescence to identify the ureters during surgery. Methods - In this study, patients undergoing abdominal surgery with high risk for ureter complications will be included. The feasibility of recruitment of these patients will be assessed using a screening log. Included patients with receive intraoperative methylene blue injection in increasing doses. Urine samples will be taken to establish the conversion of methylene blue to leucomethylene blue. Expected results - the investigators expect to define the recruitment rate of the patient group of interest and to identify the causes for non recruitment. Secondary outcomes are ureteric identification and conversion of methylene blue to leucomethylene blue.

Conditions

Interventions

TypeNameDescription
DEVICEMethylene blue fluorescenceIV administration of methylene blue, detection with deep infrared camera and light source

Timeline

Start date
2020-06-22
Primary completion
2023-07-01
Completion
2023-10-01
First posted
2021-11-08
Last updated
2022-11-01

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05111808. Inclusion in this directory is not an endorsement.